Sanofi (SNYNF)
USD 98.65
(0.0%)
USD 98.65
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 4.30 EUR | -35.58% |
| 2022 | 6.69 EUR | 34.61% |
| 2021 | 4.97 EUR | -49.34% |
| 2020 | 9.81 EUR | 321.03% |
| 2019 | 2.33 EUR | -32.46% |
| 2018 | 3.45 EUR | -48.51% |
| 2017 | 6.70 EUR | 83.06% |
| 2016 | 3.66 EUR | 11.59% |
| 2015 | 3.28 EUR | -1.8% |
| 2014 | 3.34 EUR | 18.86% |
| 2013 | 2.81 EUR | -24.05% |
| 2012 | 3.70 EUR | -13.35% |
| 2011 | 4.27 EUR | 1.91% |
| 2010 | 4.19 EUR | 3.97% |
| 2009 | 4.03 EUR | 37.07% |
| 2008 | 2.94 EUR | -24.81% |
| 2007 | 3.91 EUR | 31.65% |
| 2006 | 2.97 EUR | 76.79% |
| 2005 | 1.68 EUR | 142.42% |
| 2004 | -3.96 EUR | -234.24% |
| 2003 | 2.95 EUR | 21.9% |
| 2002 | 2.42 EUR | 11.52% |
| 2001 | 2.17 EUR | 60.74% |
| 2000 | 1.35 EUR | 58.82% |
| 1999 | 0.85 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | 2.25 EUR | 25.0% |
| 2024 Q1 | 0.91 EUR | -42.04% |
| 2024 Q2 | 1.80 EUR | 97.8% |
| 2023 Q3 | 2.01 EUR | -26.64% |
| 2023 Q4 | 1.57 EUR | -21.89% |
| 2023 Q1 | 1.60 EUR | 36.75% |
| 2023 FY | - EUR | -35.58% |
| 2023 Q2 | 2.74 EUR | 71.25% |
| 2022 Q1 | 1.61 EUR | 78.89% |
| 2022 Q2 | 0.94 EUR | -41.61% |
| 2022 Q3 | 1.66 EUR | 76.6% |
| 2022 Q4 | 1.17 EUR | -29.52% |
| 2022 FY | - EUR | 34.61% |
| 2021 Q2 | 2.22 EUR | 77.6% |
| 2021 Q3 | 1.84 EUR | -17.12% |
| 2021 Q4 | 0.90 EUR | -51.09% |
| 2021 FY | - EUR | -49.34% |
| 2021 Q1 | 1.25 EUR | 45.35% |
| 2020 Q1 | 1.35 EUR | 16975.0% |
| 2020 Q2 | 7.41 EUR | 448.89% |
| 2020 Q3 | 1.55 EUR | -79.08% |
| 2020 FY | - EUR | 321.03% |
| 2020 Q4 | 0.86 EUR | -44.52% |
| 2019 Q2 | -0.07 EUR | -107.66% |
| 2019 Q1 | 0.91 EUR | 355.0% |
| 2019 FY | - EUR | -32.46% |
| 2019 Q4 | -0.01 EUR | -100.57% |
| 2019 Q3 | 1.41 EUR | 2122.96% |
| 2018 Q1 | 0.81 EUR | 710.0% |
| 2018 Q2 | 0.61 EUR | -24.69% |
| 2018 Q3 | 1.82 EUR | 198.36% |
| 2018 Q4 | 0.20 EUR | -89.01% |
| 2018 FY | - EUR | -48.51% |
| 2017 Q1 | 4.52 EUR | 629.03% |
| 2017 Q3 | 1.25 EUR | 52.44% |
| 2017 Q4 | 0.10 EUR | -92.0% |
| 2017 FY | - EUR | 83.06% |
| 2017 Q2 | 0.82 EUR | -81.86% |
| 2016 FY | - EUR | 11.59% |
| 2016 Q2 | 0.90 EUR | 7.14% |
| 2016 Q1 | 0.84 EUR | 223.08% |
| 2016 Q4 | 0.62 EUR | -52.31% |
| 2016 Q3 | 1.30 EUR | 44.44% |
| 2015 Q3 | 1.25 EUR | 25.0% |
| 2015 FY | - EUR | -1.8% |
| 2015 Q1 | 0.78 EUR | -23.53% |
| 2015 Q4 | 0.26 EUR | -79.2% |
| 2015 Q2 | 1.00 EUR | 28.21% |
| 2014 Q2 | 0.59 EUR | -28.05% |
| 2014 Q1 | 0.82 EUR | 2.5% |
| 2014 FY | - EUR | 18.86% |
| 2014 Q3 | 0.91 EUR | 54.24% |
| 2014 Q4 | 1.02 EUR | 12.09% |
| 2013 Q2 | 0.34 EUR | -54.67% |
| 2013 Q1 | 0.75 EUR | 141.94% |
| 2013 FY | - EUR | -24.05% |
| 2013 Q4 | 0.80 EUR | -13.04% |
| 2013 Q3 | 0.92 EUR | 170.59% |
| 2012 Q4 | 0.31 EUR | -73.5% |
| 2012 FY | - EUR | -13.35% |
| 2012 Q1 | 1.37 EUR | 0.0% |
| 2012 Q3 | 1.17 EUR | 32.95% |
| 2012 Q2 | 0.88 EUR | -35.77% |
| 2011 FY | - EUR | 1.91% |
| 2011 Q4 | - EUR | -100.0% |
| 2011 Q1 | 0.93 EUR | 0.0% |
| 2011 Q2 | - EUR | -100.0% |
| 2011 Q3 | 1.52 EUR | 0.0% |
| 2010 Q3 | 1.23 EUR | 0.0% |
| 2010 FY | - EUR | 3.97% |
| 2010 Q4 | - EUR | -100.0% |
| 2010 Q2 | - EUR | -100.0% |
| 2010 Q1 | 1.31 EUR | 0.0% |
| 2009 Q1 | 1.21 EUR | 0.0% |
| 2009 FY | - EUR | 37.07% |
| 2009 Q4 | - EUR | -100.0% |
| 2009 Q3 | 1.09 EUR | 0.0% |
| 2009 Q2 | - EUR | -100.0% |
| 2008 Q1 | 0.18 EUR | 0.0% |
| 2008 FY | - EUR | -24.81% |
| 2008 Q4 | - EUR | -100.0% |
| 2008 Q3 | 1.45 EUR | 62.92% |
| 2008 Q2 | 0.89 EUR | 394.44% |
| 2007 FY | - EUR | 31.65% |
| 2007 Q3 | 0.97 EUR | -2.02% |
| 2007 Q2 | 0.99 EUR | 0.0% |
| 2007 Q1 | 0.99 EUR | 0.0% |
| 2007 Q4 | - EUR | -100.0% |
| 2006 Q2 | 0.65 EUR | -41.96% |
| 2006 FY | - EUR | 76.79% |
| 2006 Q1 | 1.12 EUR | 0.0% |
| 2006 Q4 | - EUR | -100.0% |
| 2006 Q3 | 0.60 EUR | -7.69% |
| 2005 Q2 | 0.40 EUR | -62.26% |
| 2005 Q4 | - EUR | -100.0% |
| 2005 Q3 | 0.54 EUR | 35.0% |
| 2005 Q1 | 1.06 EUR | 0.0% |
| 2005 FY | - EUR | 142.42% |
| 2004 Q1 | 1.63 EUR | 0.0% |
| 2004 FY | - EUR | -234.24% |
| 2004 Q3 | -3.39 EUR | -518.52% |
| 2004 Q2 | 0.81 EUR | -50.31% |
| 2004 Q4 | - EUR | 100.0% |
| 2003 Q1 | 0.67 EUR | 0.0% |
| 2003 Q2 | 0.67 EUR | 0.0% |
| 2003 Q3 | 0.93 EUR | 38.81% |
| 2003 Q4 | - EUR | -100.0% |
| 2003 FY | - EUR | 21.9% |
| 2002 Q3 | 0.64 EUR | 14.29% |
| 2002 Q2 | 0.56 EUR | 0.0% |
| 2002 FY | - EUR | 11.52% |
| 2002 Q4 | - EUR | -100.0% |
| 2001 FY | - EUR | 60.74% |
| 2000 FY | - EUR | 58.82% |
| 1999 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AstraZeneca PLC | 3.84 USD | -11.979% |
| Bristol-Myers Squibb Company PFD CONV 2 | 3.88 USD | -10.825% |
| CSPC Pharmaceutical Group Limited | 0.07 USD | -6042.857% |
| Clarus Therapeutics Holdings, Inc. | -8.04 USD | 153.483% |
| Novartis AG | 7.63 USD | 43.644% |
| PT Kalbe Farma Tbk. | 0.00 USD | -110156.41% |